A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
The use of capillary electrophoresis in the simultaneous determination of fixed-dose combination drugs for cardiovascular diseases
Trends in Pharmaceutical Sciences
Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide and are usually multifactorial medical conditions. Usually cardiovascular patients must follow a complicated treatment scheme, containing several drugs. Fixed dose combinations (FDCs) are pharmaceutical formulations containing two or more active ingredients in a one pill. FDCs can add multiple benefits to the treatment of CVDs including increased patient compliance, elimination of some side effects and the simultaneousdoi:10.30476/tips.2020.87276.1059 doaj:a15cfd95a0624596975c9807c9d0c6c7 fatcat:i3oqxr6wzjffdiewkmzyi5yp2e